Trade Summary

5 days ago, Ambrose Kristen, serving as SVP, Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 2,195 shares at $484.87 per share, for a total transaction value of $1,064,297.00. Following this transaction, Ambrose Kristen now holds 7,750 shares of VRTX.

This sale represents a 22.00% decrease in Ambrose Kristen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.